Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. In reply: letter

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  2. Improving postoperative pain management: what are the unresolved issues?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Early goal-directed nutrition in ICU patients (EAT-ICU): protocol for a randomised trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Impaired postural stability after laparoscopic surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Friedrich K Pühringer
  • Christopher Rex
  • Andreas W Sielenkämper
  • Casper Claudius
  • Per Bo Larsen
  • Martine E Prins
  • Matthias Eikermann
  • Karin S Khuenl-Brady
Vis graf over relationer
Sugammadex (Org 25969), a novel, selective relaxant binding agent, was specifically designed to rapidly reverse rocuronium-induced neuromuscular blockade. The efficacy and safety of sugammadex for the reversal of profound, high-dose rocuronium-induced neuromuscular blockade was evaluated.
OriginalsprogEngelsk
TidsskriftAnesthesiology News
Vol/bind109
Udgave nummer2
Sider (fra-til)188-97
Antal sider10
ISSN0747-4679
DOI
StatusUdgivet - 1 aug. 2008

ID: 32797431